<< Вернуться к списку статей журнала

Том 8 №3 2006 год - Нефрология и диализ

Сосудистое поражение почек при антифосфолипидном синдроме (Обзор литературы)

Козловская Н.Л.

Аннотация: Последние десятилетия отмечены возрастающим интересом исследователей к широкому кругу заболеваний, в основе прогрессирования которых лежат механизмы сосудистого повреждения. Он включает в себя атеросклероз, гипертоническую болезнь, сахарный диабет, системные васкулиты. В конце XX в. в этот круг вошел описанный G.R.V. Hughes антифосфолипидный синдром (АФС) - симптомокомплекс, проявляющийся венозными и/или артериальными тромбозами, привычным невынашиванием беременности и тромбоцитопенией, которые сочетаются с гиперпродукцией антител к фосфолипидам (АФЛ) [50, 54, 55]. По современным представлениям последние обуславливают развитие гиперкоагуляционного состояния свертывающей системы крови (аутоиммунной тромбофилии), реализующегося тромбообразованием в сосудах как крупного, так и малого калибра, что может приводить к развитию полиорганной ишемии, а иногда и полиорганной недостаточности

Для цитирования: Козловская Н.Л. Сосудистое поражение почек при антифосфолипидном синдроме (Обзор литературы). Нефрология и диализ. 2006. 8(3):206-219. doi:

Весь текст

Ключевые слова: антифосфолипидный синдром, антифосфолипидные антитела, АФС-ассоциированная нефропатия, тромботическая микроангиопатия

Список литературы:

1. Козловская Н.Л., Медведева Т.Ю., Мирошниченко Н.Г., Камалов Ю.Р. Тромбоз почечных вен при мембранозной нефропатии. Тер. арх. 2000; 6: 71-73.
2. Козловская Н.Л., Швецов М.Ю., Козловская Л.В. и соавт. Поражение почек у больных с антифосфолипидным синдромом при системной красной волчанке и первичным антифосфолипидным синдромом. В кн.: Мухин Н.А. (ред.). Успехи нефрологии. ММА им. И.М. Сеченова. М., 2001: 227-236.
3. Козловская Н.Л., Тареева И.Е., Камышова Е.С. и соавт. Поражение почек при первичном антифосфолипидном синдроме. Тер. арх. 2001; 73 (6): 25-31.
4. Козловская Н.Л., Шилов Е.М., Метелева Н.А., Шахнова Е.А. Нефропатия, ассоциированная с антифосфолипидным синдромом: новая форма тромботического микрососудистого поражения почек. Materia Medica 2003; 1: 15-23.
5. Метелева Н.А. Поражение почек при первичном антифосфолипидном синдроме: Автореф. дисс. … канд. мед. наук. М., 2005.
6. Мухин Н.А., Лысенко Л.В., Козловская Н.Л. и соавт. Поражение почек при антифосфолипидном синдроме. Врач 2002; 6: 13-18.
7. Решетняк Т.М. Антифосфолипидный синдром: клиника, диагностика, вопросы патогенеза: Автореф. дисс. … докт. мед. наук. М., 1999.
8. Тареева И.Е. Волчаночный нефрит. М.: Медицина, 1976: 215.
9. Швецов М.Ю. Особенности синдрома артериальной гипертонии у больных волчаночным нефритом: Автореф. дисс. … канд. мед. наук. М., 1998.
10. Шилов Е.М., Козловская Н.Л., Метелева Н.А. и соавт. Клинические проявления нефропатии, связанной с антифосфолипидным синдромом, при первичном антифосфолипидном синдроме. Тер. арх. 2003; 75 (6): 22-27.
11. D’Agati V., Kunis C., Williams G., Appel G.B. Anticardiolipin antibody and renal disease: A report of three cases. J Am Soc Nephrol 1990; 1: 777-778.
12. Alarcon-Segovia D., Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
13. Ames P.R.J., Cianciaruso B., Belizzi V. et al. Bilateral renal artery occlusion in a patient with primary antiphospholipid syndrome: thrombosis, vasculitis or both. J Rheumatol 1992; 19: 1802-1806.
14. Amigo M.-C., Garcia-Torres R., Robles M. et al. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-1185.
15. Appel G.B., Williams G.S., Meltzer J.I. et al. Renal vein thrombosis, nephrotic syndrome and systemic lupus erythematosus: an association in four cases. Ann Intern Med 1976; 85: 310-317.
16. Appel G.B., Pirani C.L., D’Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 1994; 4: 1499-1515.
17. Arnold M.H., Schrieber L. Splenic and renal infarction in systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Rheumatol 1988; 7: 406-410.
18. Asherson R.A., Lancham J.G., Hull R.G. et al. Renal vein thrombosis in systemic lupus erythematosus: association with the «lupus anticoagulant». Clin Exp Rheumatol 1984; 2: 75-79.
19. Asherson R.A., Nobel C.E., Hughes G.R.V. Hypertension, renal artery stenosis and the «primary» antiphospholipid syndrome. J Rheumatol 1991; 18 (9): 1413-1415.
20. Ascherson R.A., Khamashta M.A., Ordi-Ros J. et al. The «primary» antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68 (6): 366-374.
21. Asherson R.A., Buchanan N., Baguleu E. et al. Postpartum bilateral renal vein thrombosis in the primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1268-1272.
22. Asherson R.A. The catastrophic antiphospholipid syndrome. A review of the clinical features, possible patogenesis and treatment. Lupus 1998; 7: S55-S62.
23. Asherson R.A., Cervera R. Catastrophic antiphospholipid syndrome. Curr Opin Hematol 2000; 7: 325-329.
24. Banfi G., Bertani T., Boery V. et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991; 18: 240-248.
25. Bellomo R., Atkins R.C. Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron 1993; 6 (3): 249-254.
26. Bhandari S., Harnden P., Brownjohn A.M., Turney J.H. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephritis. Q J Med 1998; 91: 401-409.
27. Bridoux F., Vrtovsnik F., Noel Ch. et al. Renal thrombotic microangiopathy in systemic lupus erythematosus: clinical correlations and long - term renal survival. Nephrol Dial Transplant 1998; 13: 298-304.
28. Bulucu F., Can C., Oktenli C. et al. Membranous glomerulonephritis, antiphospholipid syndrome, and persistent low C3 levels associated with meningococcal disease. Nephron 2002; 91 (2): 336-338.
29. Cacoub P., Wechsler B., Piette J.C. et al. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Clin Exp Rheumatol 1993; 11 (5): 479-485.
30. Cacoub P., Piette J.C., Wechsler B. et al. Severe systemic hypertension due to renal artery lesion in systemic lupus erythematosus with antiphospholipid syndrome. Arthritis Rheum 1993; 36: 5186.
31. Cervera R., Piett J.C., Font J. et al. Antiphospholipid syndrome: clinical and immunologic manifestation and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019.
32. Cisternas M., Gutierrez M.A., Rosenberg H. et al. Catastrophic antiphospholipid syndrome associated with crescentic glomerulonephritis: a clinicopathologic case. Clin Exp Rheumatol 2000; 18 (2): 252-254.
33. Daugas E., Nochy D., Thi Huong D.L. et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002; 13: 42-52.
34. Descombes E., Droz D., Drouet L. et al. Renal vascular lesions in lupus nephritis. Medicine 1997; 76: 355-368.
35. Domrongkitchaiporn S., Cameron E.C., Jetha N. et al. Renal microangiopathy in the primary antiphospholipid syndrome: a case report with literature review. Nephron 1994; 68: 128-132.
36. Dorel M., Daniel L., Liprandi A. et al. Idiopathic membranous glomerulonephritis associated with primary antiphospholipid syndrome. Nephron 2000; 86: 366-367.
37. Durand J.M., Lefevre P., Kaplanski G. et al. Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature. Clin Rheumatol 1994; 13 (4): 635-640.
38. Espinosa G., Santos E., Cervera R. et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) 2003; 82 (2): 106-118.
39. Fakhouri F., Noёl L.-H., Zuber J. The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 2003; 41 (6): 1205-1211.
40. Farrugia E., Torres V.E., Gastineau D. et al. Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kidney Dis 1992; 20: 463-471.
41. Ferrario F., Rastaldi M.P., Pasi A. Secondary focal and segmental glomerulosclerosis. Nephrol Dial Transplant 1999; 14 (Suppl. 3): 58-67.
42. Fofi C., Cuadrado M.J., Godfrey T. et al. Lack of association between antiphospholipid antibody and WHO-classification in lupus nephritis. Clin Exp Rheumatol 2001; 19: 75-77.
43. Frampton G., Hicks J., Cameron J.S. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int 1991; 39: 1225-1231.
44. George J., Shoenfeld Y. The antiphospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 1997; 6: 559-560.
45. Gertner E., Lie J.T. Pulmonary capillaritis, alveolar hemorrhage and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1224-1228.
46. Glueck H.I., Kant K.S., Weiss M.A. et al. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 1389-1395.
47. Godfrey T., Khamashta M.A., Hughes G.R.V. Antiphospholipid syndrome and renal artery stenosis. Q J Med 2000; 93: 127-129.
48. Griffiths M.H., Papadaki L., Neild G.H. The renal pathology of primary antiphospholipid syndrome: a distinctive form of endothelial indjury. Q J Med 2000; 93: 457-467.
49. Hamidou M.A., Moreau A., Jego P. et al. Captopril and aspirin in treatment of renal microangiopathy in primary antiphospholipid syndrome. Am J Kidney Dis 1995; 25: 486-488.
50. Harris E.N., Gharavi A.E., Hughes G.R. et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
51. Hernandez D., Dominguez M.L., Diaz F. et al. Renal infarction in a severely hypertensive patient with lupus erythematosis and antiphospholipid antibodies. Nephron 1996; 72: 298-301.
52. Hess D.C., Shepard J.C., Adams R.J. Increased immunoglobulin binding to cerebral endothelium in patients with aPL. Stroke 1993; 24: 994-999.
53. Holers V.M., Girardi G., Mo L. et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195: 211-220.
54. Hughes G.R.V. Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983; 187: 1088-1089.
55. Hughes G.R.V., Harris E.N., Gharavi A.E. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-489.
56. Hughson M.D., Nadasdy T., McCarty G.A. et al. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992; 20: 150-158.
57. Jacobson H.R. Ischemic renal disease: an overlooked entity? Kidney Int 1988; 34: 729-743.
58. Joseph R.E., Radhakrishnan J., Appel G.B. Antiphospholipid antibody syndrome and renal disease. Curr Opin Nephrol Hypertens 2001; 10: 175-181.
59. Kant K.S., Pollak V.E., Weiss M.A. et al. Glomerular thrombosis in systemic lupus erythematosus : prevalence and significance. Medicine 1981; 60 (7): 71-85.
60. Karim M.Y., Alba P., Tungekar M.F. et al. Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus 2002; 11 (4): 253-256.
61. Kim J.H., Ha H.K., Yoon K.-H. et al. CT-features of abdominal manifestations of primary antiphospholipid syndrome. J Compute Assist Tomography 1999; 23: 678-683.
62. Kincaid-Smith P., Fairley K.F., Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 1988; 69: 795-815.
63. Kleinknecht D., Bobrie G., Meyer O. et al. Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant. Nephrol Dial Transplant 1989; 4: 854-858.
64. Klemperer P., Pollak A.D., Baehr G. Pathology of disseminated lupus erythematosus. Arch Pathol 1941; 32: 569-631.
65. Kolhe N., Downes M., O’Donnell P., Carmichael P. Dead on biopsy is not always dead. Nephrol Dial Transplant 2002; 17: 1843-1845.
66. Korkmaz C., Kabukcoglu S., Isiksoy S., Yalcin A.U. Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy. Lupus 2003; 12 (10): 760-765.
67. Leaker B., McGregor A., Griffits M. et al. Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt lupus nephritis. Brit J Rheumatol 1991; 30: 422-425.
68. Levine J.S., Rauch J. Renal involvement in the antiphospholipid syndrome. In: Rhematology and the kidney. Ed. by D. Adu, P. Emery, M. Madaio. Oxford University Press, 2001: 133-166.
69. Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
70. Levy Y., George J., Ziporen L. et al. Massive proteinuria as a main manifestation of primary antiphospholipid syndrome. Pathobiology 1998; 66 (1): 49-52.
71. Levy Y., Ziporen L., Gilburd B. et al. Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID-mice. Hum Antibodies Hybridomas 1996; 7 (3): 91-96.
72. Love P.E., Santoro S.A. Antiphospholipid antibodies: anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682-698.
73. Mandreoli M., Zucchelli P. Renal vascular disease in patients with primary antiphospholipid antibodies. Nephrol Dial Transplant 1993; 8: 1277-1280.
74. Matsuura E., Kobayashi K., Koike T., Shoenfeld Y. Autoantibody-mediated atherosclerosis. Autoimmun Rev 2002; 1 (6): 348-353.
75. Meroni P.L., Riboldi P. Pathogenetic mechanism mediating antiphospholipid syndrome. Curr Opin Rheumatol 2001; 13: 377-382.
76. Miller P.L., Rennke H.G., Meyer T.W. Hypertension and progressive glomerular injury caused by focal glomerular ischemia. Am J Renal Physiol 1990; 259: F239-F245.
77. Miranda J.M., Garcia-Torres R., Jara L.J. et al. Renal biopsy in systemic lupus erythematosus: significance of glomerular thrombosis. Analysis of 108 cases. Lupus 1994; 3: 25-29.
78. Moake J.L. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
79. Morgan R.J., Feneley R.C.L. Renal vein thrombosis caused by primary antiphospholipid syndrome. Br J Urol 1994; 74: 807-808.
80. Moroni G., Ventura D., Riva P. et al. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis. Am J Kidney Dis 2004; 43 (1): 28-36.
81. Moss K.E., Isenberg D.A. Comparison of renal disease and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE-alone. J Rheumatol 2001; 40: 863-867.
82. Nakano H., Tuchida H., Hamaguchi K. et al. A case of primary antiphospholipid antibody syndrome with severe nephritic syndrome showing remarkable endothelial cell damage in the capillary lumen. Nippon Jinzo Gakkati Shi 1997; 39: 431-437.
83. Nochy D., Daugas E., Droz D. et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999; 10: 507-518.
84. Nochy D., Daugas E., Thi Huong D.L. et al. Kidney involvement in the antiphospholipid syndrome. J Autoimmunity 2000; 15: 127-132.
85. Nzerue C.M., Hewan-Lowe K., Pierangeli S., Harris E.N. «Black swan in the kidney»: renal involvement in the antiphospholipid syndrome. Kidney Int 2002; 62: 733-744.
86. Ostuni P.A., Lazzarin P., Pengo V. et al. Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome. Ann Rheum Dis 1990; 49: 184-187.
87. Perez R.E., McClendon J.R., Lie J.T. Primary antiphospholipid syndrome with multiorgan arterial and venous thrombosis. J Rheumatol 1993; 20: 874-876.
88. Piette J.C., Cacoub P., Wechlser B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994; 23: 357-366.
89. Piette J.C., Kleinknecht D., Bach J.-F. Renal manifestation in the antiphospholipid syndrome. In: Asherson R., Cervera R., Piette J.C., Schoenfeld Y. (eds.). The antiphospholipid syndrome. Boca Raton: CRC Press 1996: 169-181.
90. Piette J.C. Venous vs arterial/arteriolar APS-subsets. Lupus 2002; 11(9): 634.
91. Pollak V.E., Weiss M.A. Renal vein thrombosis. In: Tisher C.C., Brenner B.M. (eds.). Renal pathology with clinical and functional correlations. Philadelphia: J.B. Lippincott Comp, 1994: 1185-1200.
92. Poux J.-M., Boudlet R., Lacroix P. et al. Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome. Am J Kidney Dis 1996; 27: 721-725.
93. Quereda C., Garcia Otero G., Pardo A. et al. Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus. Am J Kidney Dis 1994; 23 (4): 555-561.
94. Rabelink T.J., Zwaginga J.J., Koomans H.F. et al. Thrombosis and hemostasis in renal disease. Kidney Int 1994; 46: 287-296.
95. Rand J.H. Molecular patogenesis of the antiphospholipid syndrome. Curc Res 2002; 90: 29-37.
96. Remondino G.I., Mysler E., Pissano M.N. et al. A reversible bilateral renal artery stenosis in association with antiphospholipid syndrome. Lupus 2000; 9: 65-67.
97. Remuzzi G., Ruggenenti P., Bertani T. Thrombotic microangiopathy. In: Tisher C.C., Brenner B.M. (eds). Renal pathology with clinical and functional correlation. Philadelphia: J.B. Lippincott Comp, 1994: 1154-1184.
98. Remuzzi G., Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995; 48: 2-19.
99. Rollino C., Mazzucco G., Boero R. et al. Is it possible to diagnose primary antiphospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS-nephropathy) in the absence of orther thrombotic process? Ren Fail 2003; 25 (6): 1043-1049.
100. Rossi E., Sani C., Zini M. et al. Anticardiolipin antibodies and renovascular hypertension. Ann Rheum Dis 1992; 51: 1180-1181.
101. Ruggenenti P., Noris M., Remuzzi P. Thrombotic microangiopathy, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60: 831-846.
102. Ryšava R., Žabka J., Peregrin J. Acute renal failure due to bilateral renal artery thrombosis associated with primary antiphospholipid syndrome. Nephrol Dial Transplant 1998; 13: 2645-2647.
103. Sakaguchi S., Kitazawa K., Watanabe M. et al. A case of primary antiphospholipid antibody syndrome with acute renal failure showing thrombotic microangiopathy. Am J Nephrol 1999; 19: 594-598.
104. Sangle S.R., D’Cruz D.P., Jan W. et al. Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 2003; 62: 999-1002.
105. Sanna G., Bertolaccini M.L., Cuadrado M.J. et al. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatol 2003; 42: 200-213.
106. Scolari F., Savoldi S., Costantino E. et al. Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis. Nephrol Dial Transplant 1993; 8: 1274-1276.
107. Schwartz M.M. Lupus vasculatis. Contrib Nephrol 1992; 99: 35-45.
108. Sinniah R., Gan H.C., Yoon K.H. Primary antiphospholipid antibody syndrome and mesangial IgA-glomerulonephritis. Am J Nephrol 2001; 21 (2): 134-140.
109. Sipek-Dolnicar A., Hojnik M., Rozman B. et al. Small vessel thrombosis without thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome. Wien Klin Wochenschr 2000; 112 (15-16): 707-710.
110. Sipek-Dolnicar A., Hojnic M., Bozic B. et al. Clinical presentation and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies. Clin Exp Rheumatol 2002; 20 (3): 335-342.
111. Sonpal G.M., Sharma A., Miller A. Primary antiphospholipid antibody syndrome, renal infarction and hypertension. J Rheum 1993; 20: 1221-1223.
112. Tectonidou M.G., Sotsiou F., Nakopoulou L. et al. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations and long-term outcome. Arthritis Rheum 2004; 50 (8): 2569-2579.
113. Toussirot E., Figarella-Branger D., Disdier P. et al. Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology. Clin Rheumatol 1994; 13: 624-627.
114. Tsai H.-M. Advances in the patogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003; 14: 1072-1081.
115. Uwonkunda M.R., Cosyns J.P., Devogelaer J.P., Houssiau F.A. Glomerular thrombosis: an unusual cause of renal failure in systemic lupus erythematosus. Acta Clin Belg 1998; 53 (6): 371-373.
116. Vianna J.L., Khamashta M.A., Ordi-Ros J. Comparison of the primary and secondary antiphospholipid syndrome: an European multicenter study of 131 patients. Am J Med 1994; 96: 3-9.
117. Wilson W.A., Gharavi A.E., Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr Rheum 1999; 42: 1309-1311.

Другие статьи по теме

• Поражение почек при синдроме Снеддона
• Тромботическая микроангиопатия после трансплантации почки: что скрывается за морфологической картиной? Обзор литературы
• «Поздние» осложнения беременности как триггеры акушерского атипичного гемолитико-уремического синдрома
• Поражение почек при Covid-19: клинические и морфологические проявления почечной патологии у 220 пациентов, умерших от Covid-19